In this article, we will discuss Alemtuzumab (Dosage Overview). So, let’s get started.
Alemtuzumab is indicated for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Alemtuzumab should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.
The recommended dosage of Alemtuzumab is 12 mg/day administered by intravenous infusion for 2 treatment courses:
• First Treatment Course: 12 mg/day on 5 consecutive days (60 mg total dose)
• Second Treatment Course: 12 mg/day on 3 consecutive days (36 mg total dose) administered 12 months after the first treatment course.